http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104356142-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4743 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-541 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377 |
| filingDate | 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104356142-B |
| titleOfInvention | Ketone derivatives of Thiochrome [2,3 c] quinoline 12 and its preparation method and application |
| abstract | The invention discloses a series of novel Thiochrome [2,3 c] 12 ketone derivatives of quinoline, and further provide for the preparation method and applications of those derivatives, this application comprising using the analog derivative as treating cancer medical composition, and its application has the ability for substantially suppressing growth of cancer cells, the activity for suppressing first and second type Topoisomerase comprising the analog derivative, and then the effects such as treating cancer. |
| priorityDate | 2014-10-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 164.